Jump to page content Accessibility
News, views and contacts from the global Pharmaceutical industry
Login to pharmaceutical-technology.com Log in or Register
  • Home
  • Products & Services
  • Company A - Z
  • Projects
  • Features
  • Videos
  • White Papers
  • News
  • Events
  • Advertise With Us
Latest Features | Features A - Z | Contributors
 

How the UK Beat the Virus: H1N1's Controversy



Dr Alan McNally argues that a swift response to the swine flu virus lowered the risk of infection and number of deaths.


  • Dr Alan McNally argues that a swift response to the swine flu virus lowered...

  • Some feel that the world overreacted to the dangers of swine flu and its...

  • Professor Robert Dingwall, speaking at a seminar at the Biocity centre in...

  • It was thought, however, that giving Tamiflu to those who had been in near...

  • The world's response to swine flu was no overreaction, but helped to halt the...

Back to Feature Details



Related Features

Delay at the FDA
The US Food and Drug Administration has come under criticism recently...

Beating the Big C
The global market for cancer drugs is growing rapidly, but are we any...

Reality Bites: Disappointment in the R&D Sector
The pharmaceuticals industry is investing twice as much in R&D as it was...

Amendments Set to Clear Ambiguity
The US government is imposing transparency rules on the relationship...

The Witty Answer to GSK's Future
Has Andrew Witty got what it takes to keep GlaxoSmithKline at the top?...

See all features



Follow Us:
Twitter Twitter   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

pharmaceutical-technology.com is a product of Net Resources International. Copyright 2011 Net Resources International, a trading division of SPG Media Limited.